The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Arbutus Biopharma Corporation(NASDAQ:ABUS) 
Arbutus Biopharma Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of a cure for patients suffering from chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously-del...
Website: http://www.arbutusbio.com
Founded: 2007
Full Time Employees: 78
CEO: William Bill Collier
Sector: Healthcare
Industry: Biotechnology
Arbutus Biopharma Days Payable Outstanding ttm (DPO)
Arbutus Biopharma Days Receivable Outstanding ttm (DSO)
Arbutus Biopharma Op Cashflow Per Share ttm
Arbutus Biopharma Free Cashflow Per Share ttm
Arbutus Biopharma Cash Per Share ttm
Arbutus Biopharma P/S ratio ttm
Arbutus Biopharma (GAAP) P/E ratio ttm
Arbutus Biopharma P/B ratio ttm
No extra charts and metrics for this ticker.